menu search

Regeneron Reports Third Quarter 2023 Financial and Operating Results

Regeneron Reports Third Quarter 2023 Financial and Operating Results
Third quarter 2023 revenues increased 15% to $3.36 billion versus third quarter 2022 Third quarter 2023 Dupixent® global net sales (recorded by Sanofi) increased 33% to $3.10 billion versus third quarter 2022 Third quarter 2023 U.S. net sales for EYLEA® and EYLEA HD were $1.49 billion, including $43 million from EYLEA HD Third quarter 2023 Libtayo® global […] The post Regeneron Reports Third Quarter 2023 Financial and Operating Results appeared first on ForexTV... Read More
Posted: Nov 2 2023, 10:30
Author Name: forextv
Views: 112173

Search within

Pages Search Results: